Lower cerebral blood flow in subjects with Alzheimer's dementia, mild cognitive impairment, and subjective cognitive decline using two‐dimensional phase‐contrast magnetic resonance imaging
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Introduction: In this cross‐sectional study, we aimed to detect differences in cerebral blood flow (CBF) between subjects with Alzheimer's disease (AD), mild cognitive impairment (MCI), and subjective cognitive decline (SCD), using two‐dimensional phase‐contrast magnetic resonance imaging. Methods: We included 74 AD patients (67 years, 51% female), 36 MCI patients (66 years, 33% female), and 62 patients with SCD (60 years, 32% female) from the Amsterdam Dementia Cohort. Patients with SCD are those who visited the memory clinic with subjective cognitive complaints without objective cognitive impairment. Whole‐brain CBF (mL/100 g/min) was calculated using total volume flow measured with two‐dimensional phase‐contrast magnetic resonance imaging and normalized for brain volume. Results: Mean CBF values (SD) were lower in AD compared to SCD (age and sex adjusted 70 ± 26 vs. 82 ± 24 mL/100 g/min, P < .05). Mean CBF values of MCI were comparable to AD. Across clinical groups, lower CBF was associated with lower scores on the Mini–Mental State Examination (age and sex adjusted stβ = 0.19 per mL/100 g/min; P = .02). Discussion: Lower whole‐brain CBF is seen in AD patients compared to SCD patients and is associated with worse cognitive function.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Petersen, R. C., Stevens, J. C., Ganguli, M., Tangalos, E. G., Cummings, J. L., & DeKosky, S. T. (2001) · Neurology · doi:10.1212/wnl.56.9.1133 · Cited by 2,065
Jack, C. R., Albert, M. S., Knopman, D. S., McKhann, G. M., Sperling, R. A., Carrillo, M. C., Thies, B., & Phelps, C. H. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.004 · Cited by 2,042 · cited 1×
“Alzheimer’s disease (AD) is a progressive neurodegenerative disease caused by accumulation of amyloid plaques and neurofibrillary tangles, eventually leading to brain atrophy [1].”
BackgroundJack, C. R., Lowe, V. J., Weigand, S. D., Wiste, H. J., Senjem, M. L., Knopman, D. S., Shiung, M. M., Gunter, J. L., Boeve, B. F., Kemp, B. J., et al. (2009) · Brain · doi:10.1093/brain/awp062 · Cited by 1,099
Cerebral microbleeds are associated with worse cognitive function: The Rotterdam Scan Study
Poels, M. M. F., Ikram, M. A., van der Lugt, A., Hofman, A., Niessen, W. J., Krestin, G. P., Breteler, M. M. B., & Vernooij, M. W. (2012) · Neurology · doi:10.1212/wnl.0b013e3182452928 · Cited by 378
The Utility of Cerebral Blood Flow as a Biomarker of Preclinical Alzheimer’s Disease
Hays, C. C., Zlatar, Z. Z., & Wierenga, C. E. (2016) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-015-0261-z · Cited by 213 · cited 2×
“Single-photon emission computed tomography and PET are invasive, and ASL is very sensitive to measurement variability [8].”
BackgroundVernooij, M. W., van der Lugt, A., Ikram, M. A., Wielopolski, P. A., Vrooman, H. A., Hofman, A., Krestin, G. P., & Breteler, M. M. (2008) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600526 · Cited by 156 · cited 7×
“All analyses were adjusted for age and sex and additionally for cardiovascular risk factors (hypertension, hypercholesterolemia, diabetes mellitus, and smoking) and separately for MRI markers of SVD (lacunes, WMHs, and micro- bleeds).”
BackgroundInfluentialReduced Cerebral Blood Flow in Mild Cognitive Impairment Assessed Using Phase-Contrast MRI
de Eulate, R. G., Goñi, I., Galiano, A., Vidorreta, M., Recio, M., Riverol, M., Zubieta, J. L., & Fernández-Seara, M. A. (2017) · Journal of Alzheimer’s Disease · doi:10.3233/jad-161222 · Cited by 48 · cited 2×
“Two small studies and one larger study showed that 2D PC imaging is capable of measuring whole-brain CBF, which can be used to differentiate between subjects with SCD and with AD [6,11,12].”
Background
Cited by
The role of brain vasculature in neurodegenerative disorders
Sweeney, M. D., Kisler, K., Montagne, A., Toga, A. W., & Zlokovic, B. V. (2018) · Nature Neuroscience · doi:10.1038/s41593-018-0234-x · Cited by 998
Vascular dysfunction—The disregarded partner of Alzheimer's disease
Sweeney, M. D., Montagne, A., Sagare, A. P., Nation, D. A., Schneider, L. S., Chui, H. C., Harrington, M. G., Pa, J., Law, M., Wang, D. J. J., et al. (2019) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.07.222 · Cited by 711
“[40] Leijenaar JF, van Maurik IS, Kuijer JPA, van der Flier WM, Scheltens P, Barkhof F, et al.”
Implicating endothelial cell senescence to dysfunction in the ageing and diseased brain
Graves, S. I., & Baker, D. J. (2020) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.13403 · Cited by 118
Hussein, R., Shin, D., Zhao, M. Y., Guo, J., Davidzon, G., Steinberg, G., Moseley, M., & Zaharchuk, G. (2024) · Medical Image Analysis · doi:10.1016/j.media.2023.103072 · Cited by 9
Metadata
- Authors
- Leijenaar, J. F., van Maurik, I. S., Kuijer, J. P. A., van der Flier, W. M., Scheltens, P., Barkhof, F., & Prins, N. D.
- Venue
- Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
- Publisher
- Wiley
- Published
- 2017-01
- Volume
- 9
- Issue
- 1
- Pages
- 76-83
- ISSN
- 2352-8729 (ISSN-L)
- OpenAlex
- W2765561888
- Cited by
- 59
- References
- 7
- FWCI
- 4.98
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Lower cerebral blood flow in subjects with Alzheimer's dementia, mild cognitive impairment, and subjective cognitive decline using two‐dimensional phase‐contrast magnetic resonance imaging. https://app.cochat.ai/papers/10.1016/j.dadm.2017.10.001
- The paper
- Leijenaar, J. F., van Maurik, I. S., Kuijer, J. P. A., van der Flier, W. M., Scheltens, P., Barkhof, F., & Prins, N. D. (2017). Lower cerebral blood flow in subjects with Alzheimer's dementia, mild cognitive impairment, and subjective cognitive decline using two‐dimensional phase‐contrast magnetic resonance imaging. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring. https://doi.org/10.1016/j.dadm.2017.10.001
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.